The immunocompromised dermatology patient and COVID-19

Authors
Category Primary study
Year 2020
In light of the ongoing pandemic, Vivian Shi, M.D., discusses potential risks dermatologists will want to keep in mind when evaluating patients currently taking immunomodulator or immunosuppressant drugs.
Epistemonikos ID: 2f172b10fff1140a44889d0a81189e20d6fb723a
First added on: Feb 02, 2021